Glaukos has been granted a patent for a corneal cross-linking system that utilizes a light source and a spatial light modulator to deliver pixelated illumination. The system adapts to corneal movement, ensuring effective photoactivation of a cross-linking agent across the treatment area. GlobalData’s report on Glaukos gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Glaukos, Customized implants was a key innovation area identified from patents. Glaukos's grant share as of June 2024 was 41%. Grant share is based on the ratio of number of grants to total number of patents.
Corneal cross-linking treatment system with pixelated illumination
The patent US12042433B2 describes a sophisticated system designed for applying a cross-linking treatment to the cornea of the eye. Central to this system is a light source that emits photoactivating light, which is modulated by a spatial light modulator (SLM) to create pixelated illumination patterns. The controller orchestrates the projection of two distinct pixelated illuminations onto the cornea, targeting a specific treatment area. Notably, the first illumination covers the desired area, while the second illumination fills in any gaps, ensuring comprehensive coverage. The system allows for the projection of multiple illuminations with varying temporal and spatial profiles, enhancing the effectiveness of the cross-linking agent applied to the cornea.
Further details reveal that the SLM can be a Digital Micromirror Device (DMD), which utilizes an array of mirrors to reflect the photoactivating light. The system is designed to adapt to the movement of the cornea, allowing the controller to adjust the illumination patterns dynamically. This adaptability ensures that the treatment remains effective even if the eye shifts during the procedure. The claims also outline the potential for additional pixelated illuminations to be projected, further optimizing the treatment area coverage. Overall, this innovative system aims to improve the precision and efficacy of corneal cross-linking treatments, potentially benefiting patients with various corneal conditions.
To know more about GlobalData’s detailed insights on Glaukos, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
